Case Study: AstraZeneca boosts rep engagement and HCP education with ACTO

AstraZeneca boosts rep engagement with ACTO and drives 5,000+ content pulls

astrazeneca partnered with ACTO and Axiom on the Triple A Initiative to launch a new indication for a diabetes drug. The challenge was to equip a large number of sales representatives to educate healthcare professionals on the drug's new clinical story in a compliant manner without taking up too much time out of their territory.

The solution, powered by the ACTO platform, provided a mobile-first, microlearning experience for reps and delivered actionable data insights to leadership. This resulted in a significant increase in rep engagement with over 5,000 content pulls, more effective conversations with healthcare professionals, and the establishment of a data-driven culture for continuous program improvement.

AstraZeneca